Roche Holding AG
Открыт
СекторЗдравоохранение
330.4
Обзор
Изменение цены акций
24 ч
Мин.
321.8
Макс.
331
Доход | 1.8B 5.5B |
|---|---|
Продажи | 15B 31B |
P/E Средняя по отрасли | 20.262 49.052 |
Дивидендная доходность | 2.98 |
Рентабельность продаж | 17.892 |
Сотрудники | 103,249 |
EBITDA | 5.1B 12B |
Дивидендная доходность Средняя по отрасли | 2.98% 2.36% |
|---|
Рыночная капитализация | -30B 259B |
|---|---|
Предыдущая цена открытия | 330.4 |
Предыдущая цена закрытия | 330.4 |
Новостные настроения
By Acuity
69%
31%
311 / 342 Рейтинг в Healthcare
Roche Holding AG График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
